The Latest Life Sciences Tools & Diagnostics Articles from Streetwise Reports


Dexcom Posts 49% YoY Revenue Growth, Sending Shares to 52-Week High

  ()
Glucose monitoring systems developer Dexcom's shares traded 30% higher after releasing Q3/19 earnings and raising full-year 2019 guidance. read more >

Fulgent Genetics Hits 52-Week High After Posting 84% Q3 Revenue Increase

  ()
Fulgent Genetics shares traded more than 40% higher after the company reported record revenue in Q3/19. The firm noted that it completed a record 20,697 billable tests in the quarter, up 272% over the same period last year. read more >

Navidea Shares Jump 60% on Phase 2b Rheumatoid Arthritis Trial Results

  ()
Shares of Navidea Biopharmaceuticals traded greatly higher on extremely high relative volume after the firm released data from its Phase 2b Rheumatoid Arthritis Tc 99m Tilmanocept Planar Imaging study. read more >

New Data Could Drive Use of Pancreatic Cancer Early Detection Test

Research Report
  ()
The recent results and their implications are provided in an H.C. Wainwright & Co. report. read more >

Technical Analyst Expects Health Technologies Firm to Break Higher

Contributed Opinion
  ()
Technical analyst Clive Maund outlines the reasons this stock might break higher. read more >

Guardant Health Reports Quarterly Revenue Up 178%

  ()
Guardant Health Inc. reported strong growth for Q2/19 versus the same period last year and raised its full-year 2019 revenue guidance to $180–190 million. read more >

Biotech's Mosquito Test 'Gains Market Acceptance'

Research Report
  ()
This West Nile virus test and others including cancer diagnostic tests in the Utah company's pipeline are discussed in an H.C. Wainwright & Co. report. read more >

Tandem Increases Unit Sales of t:slim X2 Insulin Pumps 290% Worldwide

  ()
Tandem Diabetes Care's second quarter earnings highlighted a 290% increase in unit sales of its t:slim X2 insulin pumps that feature integrated continuous glucose monitoring and remote software update capability. read more >

Technical Analyst: Medical Device Stock Looking Set to Reverse

Contributed Opinion
  ()
Technical analyst Clive Maund charts the stock of this company that has developed a device that uses a special light that visualizes cancer during minimally invasive surgery. read more >

Health Technology Company Recuperating Well

Contributed Opinion
  ()
Technical analyst Clive Maund charts a medical technology firm and explains why he believes it is an interesting speculative play. read more >

Bacteria Test Developer Reiterates Revenue Should Double in 2019

Research Report
  ()
The product expected to drive that outcome is discussed in an H.C. Wainwright & Co. report. read more >
News Update

Healthcare Firm Partners on Genetic Testing for Cannabis, Medication Responses

News Update
  ()
The offering should facilitate a more individualized treatment plan for patients. read more >
Showing Results: 1 to 12 of 12

Get Our Streetwise Reports Newsletter Free and be the first to know!

A valid email address is required to subscribe

More Experts

"Sprott's investment gives MMG the funds to continue exploring Keno." ❭
– Brien Lundin, Gold Newsletter (Jefferson Financial)
"We highlight the considerable exploration upside at MAG's Juanicipio." ❭
– Kevin MacKenzie, PI Financial
"PGE is on the radar of majors but under the radar of investors." ❭
– James Kwantes, Resource Opportunities
"POE plans an aggressive drill campaign in the north L53-DD field." ❭
– Chen Lin, What Is Chen Buying? What Is Chen Selling?
"DRRX's psoriasis trial is on target for topline data by year-end 2019." ❭
– Ed Arce, H.C. Wainwright & Co.